← back to search

Maria Dorobanţu

Medical Research Council ·
Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Blood Pressure and Hypertension Studies, Cardiovascular Function and Risk Factors, Acute Myocardial Infarction Research, and Cardiac Imaging and Diagnostics.
h-index
52
citations
60,029
works
420
NIH funding
primary concept
Medicine
email

Recent publications

Changing clinical perspectives on sex and healthcare disparities in ischaemic heart disease
The Lancet Regional Health - Europe 2025cited by 9position: middledoi
National evidence on glucose-lowering medication use for diabetes from 62 low- and middle-income countries
Nature Communications 2025cited by 4position: middledoi
Academia Europaea’s guidelines for the visualization of clinical outcomes
Nature Medicine 2025cited by 1position: middledoi
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
European Heart Journal - Cardiovascular Pharmacotherapy 2024cited by 19position: middledoi
Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire
Journal of Hypertension 2024cited by 5position: middledoi
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Journal of Hypertension 2023cited by 2,966position: middledoi
Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact
The Lancet 2023cited by 215position: middledoi
Rural-Urban Differences in Diabetes Care and Control in 42 Low- and Middle-Income Countries: A Cross-sectional Study of Nationally Representative Individual-Level Data
Diabetes Care 2022cited by 53position: middledoi
The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults
The Lancet Healthy Longevity 2021cited by 258position: middledoi
Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults
The Lancet 2021cited by 154position: middledoi
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study
European Heart Journal 2021cited by 106position: middledoi
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Diabetes Care 2021cited by 35position: middledoi
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
The Lancet 2020cited by 751position: middledoi
Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis
Cardiovascular Research 2020cited by 374position: middledoi
Diabetes Prevalence and Its Relationship With Education, Wealth, and BMI in 29 Low- and Middle-Income Countries
Diabetes Care 2020cited by 172position: middledoi
The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults
The Lancet 2019cited by 855position: middledoi
Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation
European Heart Journal 2019cited by 381position: middledoi
Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys
PLoS Medicine 2019cited by 323position: middledoi
Effects of Serelaxin in Patients with Acute Heart Failure
New England Journal of Medicine 2019cited by 260position: middledoi
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis
European Heart Journal 2019cited by 87position: middledoi
Rationale and Design of the AFFIRM-AHF Trial: A Randomised, Double-Blind, Placebo-Controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron-Deficient Patients Admitted for Acute Heart Failure
European Journal of Heart Failure 2019cited by 53position: middledoi
2018 ESC/ESH Guidelines for the management of arterial hypertension
European Heart Journal 2018cited by 10,351position: middledoi
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol
BMJ Open 2018cited by 39position: middledoi
Presentation, management, and outcomes of ischaemic heart disease in women
Nature Reviews Cardiology 2013cited by 113position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lina Badimón · Instituto de Investigación de Enfermedades Raras4 papers (2013–2025)Edina Cenko · Health Care Foundation3 papers (2013–2025)Raffaele Bugiardini · Health Care Foundation3 papers (2013–2025)Viola Vaccarino · Emory University3 papers (2013–2025)Olivia Manfrini · GNA University3 papers (2013–2025)Danijela Trifunović · University of Belgrade2 papers (2019–2020)Cor de Wit · German Centre for Cardiovascular Research2 papers (2013–2019)Axel R. Pries · World of Medicine (Germany)2 papers (2013–2019)Ákos Koller · University of Oklahoma Health Sciences Center2 papers (2013–2019)Dirk J. Duncker · Erasmus MC2 papers (2019–2020)Davor Miličić · University Hospital Centre Zagreb2 papers (2019–2019)Christian Weber · Dana-Farber Cancer Institute1 papers (2020–2020)Stefan D. Anker · Council for British Research in the Levant1 papers (2019–2019)Roberto Corti · Klinik Hirslanden1 papers (2013–2013)M. Yvonne Alexander · University of Manchester1 papers (2020–2020)Paul Morris · Sheffield Teaching Hospitals NHS Foundation Trust1 papers (2020–2020)Peter van der Meer · University College London1 papers (2019–2019)David Sim · SingHealth1 papers (2019–2019)Rody G. Sy · Columbia University1 papers (2019–2019)Daniel Wojdyla · University of Kentucky1 papers (2019–2019)